Impel NeuroPharma is pleased to announce that H. Stewart Parker, a prominent leader in Seattle’s Biotechnology community, has joined Impel’s Board of Directors.
Most recently, Parker was the CEO of the Seattle-based Infection Disease Research Institute (IDRI), a nonprofit global health research institute developing diagnostics, vaccines, and treatments for neglected diseases. Parker started her career in biotech as the first employee of Immunex, growing with the company to become Vice President of Corporate Development.
Help employers find you! Check out all the jobs and post your resume.
